Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diphosgene | HCID 10426 | — |
| Reactant | Tetrahydro-4H-pyran-4-ol | HCID 74956 | — |
| Reactant | HCID 178455377 | HCID 178455377 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | HCID 178455381 | HCID 178455381 | — |
Reaction Steps
(cis)-4-(4-(2-((3R,3aR,6R,6aS)-6-(tert-Butyldimethylsilyloxy)hexahydrofuro[3,2-b]-furan-3-yloxy)-6-chloro-3-((2-(trimethylsilyl)ethoxy)methyl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)cyclohexanamine (40 mg) is dissolved in toluene (2 mL), treated dropwise with a solution of diphosgene (6.8 μL) in toluene (2 mL), stirred for 10 minutes at room temperature and for 1.5 hours at 60° C. Then tetrahydro-2H-pyran-4-ol (5.3 μL) is added and the mixture is stirred for 48 hours at 60° C. The mixture is partitioned between ethylacetate and saturated aqueous NH4Cl solution. The organic phase is dried (MgSO4) and concentrated. The crude product is used directly in the next step.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09187477B2 |
|---|
| Source dataset | uspto-grants-2015_11 |
|---|
| ORD ID | ord-c69e16bf0fdb4ab18bf44d3854f5ab20 |
|---|
| Source note | uspto-grants-2015_11 |
|---|